Options for skin quality, facial volume, expression and the scalp. Product, area and individual needs are considered together; there is no universal treatment plan.
Explore the treatments
An umbrella term for injectable approaches to facial volume changes. The treatment combination depends on individual needs.
Consultation covers the proposed change, alternatives and injection-related risks.
Fillers can address selected hollows and contours. They do not remove excess skin or reproduce a surgical facelift.
Small injections deliver a selected preparation into the skin. Ingredients and treatment goals differ between products.
Product ingredients, allergy history and skin suitability are reviewed beforehand.
Specific hyaluronic acid formulations have been studied for hydration and skin texture. Those findings cannot be extended to every mesotherapy mixture.
A group of injection-based approaches to the scalp. The cause of hair loss must be assessed first.
Options are compared against the diagnosis; hair regrowth cannot be guaranteed.
Studies use different preparations and protocols. A single expected benefit or session schedule cannot be assumed for every type of hair loss.
Injectable approaches addressing neck texture and fine lines. Product selection follows an assessment of the skin.
Planning includes possible temporary swelling, bruising and tenderness.
Specific hyaluronic acid treatments have been evaluated in neck-line studies. Surface lines and substantial skin laxity require different considerations.
Injectable approaches to skin texture on the upper chest. The choice depends on individual skin needs.
Sun damage, skin lesions and product suitability are assessed beforehand.
Specific hyaluronic acid preparations have been examined in small clinical studies in this area. Findings do not establish the same result for every product or sign of skin ageing.
An umbrella term for some skin-quality injections, also marketed in Turkish as a 'youth vaccine'. They are not immunising vaccines.
Benefits and risks are assessed for the specific product, not its marketing name.
The name does not identify one standard ingredient or procedure. The consultation clarifies the product, its components and the intended change.
A common name for some polynucleotide or PDRN skin treatments. Formulations and intended uses vary.
The product source, allergy history and limits of expected benefit are discussed.
Small clinical trials have explored the skin effects of specific products. These findings do not establish guaranteed rejuvenation or identical effects across products.
Platelet-rich plasma is prepared from a person's own blood. Its use for skin is assessed separately from scalp treatment.
Blood disorders, medicines and injection-related risks are reviewed.
Facial skin studies have not produced consistent results. A standard or guaranteed rejuvenation effect should therefore not be assumed.
PRP prepared from your blood is considered for treatment of the scalp. It is not suitable for every form of hair loss.
Diagnosis and other options are considered together; individual results vary.
It may form part of a treatment plan for selected hereditary hair-loss patterns. The cause, duration and remaining hair influence the response.
Filler treatment addressing lip volume and shape. Facial proportions and existing lip anatomy are assessed together.
Risks include swelling and bruising, as well as rare serious vascular complications.
Choosing a product involves more than adding volume. Planning also considers the lip border, movement and personal expectations.
Considered for selected areas of facial volume loss and contour change. Filler is not the answer to every line or area of laxity.
Previous filler products and treatment history should be shared during consultation.
Different facial regions are assessed together. Duration depends on the product and treated area; permanence is not assumed.
Considered for chin contour and its relationship to the profile. It is not surgery that changes the underlying bone.
Consultation covers product selection, the intended change and possible asymmetry.
Front and profile proportions are considered together. Bite or skeletal concerns may require a separate assessment.
Filler treatment addressing the lower-jaw contour. Planning considers the chin, neck and overall facial proportions.
The whole face is assessed to avoid unnecessary additional volume.
The aim is to address selected contour deficits. Significant excess skin or submental fat may require a different approach.
Focuses on midface volume and cheek contour. Natural anatomy and overall facial balance guide assessment.
One volume or facial shape is not suitable for everyone.
The cheekbone itself is not changed; treatment addresses surrounding soft-tissue volume. Suitability depends on expectations and existing volume distribution.
Addresses the folds running from the nose toward the mouth corners. These folds are also part of normal facial movement.
As with other facial fillers, vascular complication risks must be discussed.
The fold and surrounding tissues are examined together. Goals and product choice depend on its cause and overall facial structure.
A filler approach for selected under-eye hollows. Not every dark circle or eye bag is suitable for filler.
Risks include swelling, irregularity and rare serious vascular events, including loss of vision.
Hollowing, pigment, skin characteristics and swelling are assessed separately. Patient and product selection are particularly important around the eyes.
Considered for loss of volume in the temple area. Planning looks at the upper face as a whole.
Rare vascular blockage and vision loss make particular caution necessary.
The vascular anatomy requires careful assessment. Alternatives and risks are discussed alongside the desired contour change.
Botulinum toxin temporarily reduces activity in selected muscles. It is considered for certain expression-related lines.
Possible temporary asymmetry or muscle weakness is discussed with the physician.
Individual movement patterns are assessed in areas such as the forehead, frown and eye region. It works differently from filler and does not add volume.
Targets activity in the masseter chewing muscle. Suitability depends on the cause of the concern and muscle characteristics.
Reduced chewing strength and temporary changes in the smile are discussed.
For clenching or jaw symptoms, it does not replace dental and jaw assessment. Cosmetic expectations related to muscle volume are considered separately.
Botulinum toxin may be considered for selected cases of excessive sweating. Underlying causes are assessed first.
The effect is temporary; follow-up and repeat treatment needs vary.
It is one option used particularly for excessive underarm sweating. Suitability considers responses to other measures and overall health.
This information is a general guide. Suitability, the method or product, potential risks and recovery are discussed in an individual medical assessment. Images are representative digital artworks, not patient results or injection maps.
Your expectations, your questions, your story.
It all begins with listening to you.
